NRG1 and breast cancer: Here we describe that human BT474 breast cancer cells endogenously express functionally active μ-opioid receptors and that chronic Morphine treatment produces fundamental changes in the ErbB receptor network resulting in attenuation of Heregulin-stimulated cell growth.